Triazolopyrazine
US9428513B2 · kind B2 · utility
2Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 4, 2014 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Nov 4, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention encompasses compounds of general formula (I)wherein the groups R1 to R3, X3 to X6 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.